Treo Citrus Freyðitafla 500/50 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

treo citrus freyðitafla 500/50 mg

viatris aps - acidum acetylsalicylicum; coffeinum - freyðitafla - 500/50 mg

Treo Freyðitafla 50 mg/ 500 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

treo freyðitafla 50 mg/ 500 mg

viatris aps - coffeinum; acidum acetylsalicylicum - freyðitafla - 50 mg/ 500 mg

Treo Hindbær Freyðitafla 500/50 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

treo hindbær freyðitafla 500/50 mg

viatris aps - coffeinum; acidum acetylsalicylicum - freyðitafla - 500/50 mg

Treo Freyðitafla 500 mg/50 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

treo freyðitafla 500 mg/50 mg

viatris aps - acidum acetylsalicylicum; coffeinum - freyðitafla - 500 mg/50 mg

Orfiril Magasýruþolin tafla 150 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

orfiril magasýruþolin tafla 150 mg

desitin arzneimittel gmbh - natrii valproas - magasýruþolin tafla - 150 mg

Orfiril Magasýruþolin tafla 600 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

orfiril magasýruþolin tafla 600 mg

desitin arzneimittel gmbh - natrii valproas - magasýruþolin tafla - 600 mg

Orfiril Mixtúra, lausn 60 mg/ml أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

orfiril mixtúra, lausn 60 mg/ml

desitin arzneimittel gmbh - natrii valproas - mixtúra, lausn - 60 mg/ml

Orfiril Retard Forðatafla 300 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

orfiril retard forðatafla 300 mg

desitin arzneimittel gmbh - natrii valproas - forðatafla - 300 mg

Ertapenem SUN الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

ertapenem sun

sun pharmaceutical industries (europe) b.v. - natríum ertapenem - bakteríusýkingar - ertapenem - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 og 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.

Xyrem الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

xyrem

ucb pharma ltd - natríumoxýbat - cataplexy; narcolepsy - Önnur lyf í taugakerfinu - meðferð við narkólsi með kataplexi hjá fullorðnum sjúklingum.